Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > General Partner walk in...$15 / $18 ...$25???
View:
Post by ForRealNowAndNo on Aug 16, 2016 11:03am

General Partner walk in...$15 / $18 ...$25???

What would a GP be willing to pay to get in? And how much CXR needs to raise? If they plan to go international, they absolutely need a GP. While encouraging, this dilutes the stock further and it will take longer to built value. I think this is what Thompson's after. He must negotiate and get the OK from his creditors though.
Comment by derekli on Aug 16, 2016 11:07am
a good point, seems selling drug to other Africa Asian middle east, Can solve problem of the drug competition (their most competition from USA).this can create a huge profit
Comment by Juice004 on Aug 16, 2016 11:11am
For the amount of risk they are taking probably closer to book value which is still lower from these levels
Comment by ForRealNowAndNo on Aug 16, 2016 11:16am
Pharma's one if not the biggest lobby. Financiers play now along the political lines, but in the end healthcare will make money.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities